METTL1 and early-onset autosomal dominant Alzheimer disease: Recently, METTL1 and its mediated m7G modifications have been found to play an essential role in neurodegenerative diseases, including Alzheimer’s disease, and in the malignant progression of tumors [3, 7, 8, 21–23].